MP

Madhavan Pillai Branesh

Active Director Director DIN 10334489
DIN 10334489 First appointment Sep 2023 Primary industry Business Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Madhavan Pillai Branesh

Data last updated:

Madhavan Pillai Branesh is a Director at Synthesis Healthcare Edu Robotics Private Limited (since 2023). The company operates in Business Services.

DIN 10334489
Primary Designation Director
Industry Business Services
First Appointment 25 Sep 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director25 Sep 20232023Active

Board colleagues of Madhavan Pillai Branesh

Directorship timeline

Open interactive timeline →
Synthesis Healthcare Edu Robotics Private Limited
Premium access

Shareholding and investment profile for Madhavan Pillai Branesh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Madhavan Pillai Branesh

Madhavan Pillai Branesh currently holds 1 directorship: Synthesis Healthcare Edu Robotics Private Limited (Director, since 25 Sep 2023).

Madhavan Pillai Branesh was first appointed on 25 Sep 2023 as Director at Synthesis Healthcare Edu Robotics Private Limited.

The current boards of Madhavan Pillai Branesh's companies include Kotra Krishna Mohan (Synthesis Healthcare Edu Robotics Private Limited), Sathyananthan Priya (Synthesis Healthcare Edu Robotics Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available